Skip to content

Meet TCG
Our Portfolio
In the News
Join our Ecosystem

Contact Us
Investor Login

Contact Us
Investor Login

Portfolio News

Carmot Therapeutics Initiates the Clinical Program for CT-388, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Patients with Type 2 Diabetes and Showcases its Technology at the Upcoming American Diabetes Association Scientific Session

Portfolio News / By Karina Tin

June 24, 2021

Carmot Therapeutics Initiates the Clinical Program for CT-388, a Dual GLP-1 and GIP Receptor Modulator for the Treatment of Patients with Type 2 Diabetes and Showcases its Technology at the Upcoming American Diabetes Association Scientific Session Read More »

Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders

Portfolio News / By Karina Tin

June 22, 2021

Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders Read More »

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

Portfolio News / By Karina Tin

June 21, 2021

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development Read More »

RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Portfolio News / By Karina Tin

June 18, 2021

RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications

Portfolio News / By Karina Tin

June 17, 2021

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications Read More »

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI)

Portfolio News / By Karina Tin

June 16, 2021

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI) Read More »

Circle Pharma raises $66 Million in Series C Financing

Portfolio News / By Karina Tin

June 16, 2021

Circle Pharma raises $66 Million in Series C Financing Read More »

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

Portfolio News / By Karina Tin

June 15, 2021

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock Read More »

RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis

Portfolio News / By Karina Tin

June 14, 2021

RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis Read More »

Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform

Portfolio News / By Karina Tin

June 10, 2021

Synthekine Announces $107.5 Million Oversubscribed Series B Financing to Support Lead Programs to Clinical Proof of Concept, Advance Preclinical Programs and Platform Read More »

← Previous 1 … 57 58 59 … 78 Next →

Meet TCG
Our Portfolio
In The News
Join Our Ecosystem
Contact Us
Investor Login

Meet TCG
Join Our Ecosystem
Our Portfolio
Contact Us
In The News
Investor Login

Copyright © 2026. The Column Group

Privacy Policy
Terms of Use

Scroll to Top